Erlotinib and Gemcitabine With or Without Panitumumab in Treating Patients With Metastatic Pancreatic Cancer

NCT00550836 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

104

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

BIOLOGICAL: panitumumab
DRUG: erlotinib hydrochloride
DRUG: gemcitabine hydrochloride

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]